Search results for "Angina"

showing 10 items of 211 documents

Ludwig's angina and ketoacidosis as a first manifestation of diabetes mellitus

2009

Ludwig?s angina is a serious and rapidly progressive infectious process that spreads through the floor of the mouth and neck. In this paper we present an infrequent case of a patient who suffered an odontogenic infection with poor response to the previous treatment, which evolved towards a Ludwig?s angina combined with ketoacidosis in the context of a diabetes mellitus not known before. According to the literature reviewed, this case report represents the first contribution of a Ludwig?s angina and ketoacidosis as an initial manifestation of a diabetes mellitus. The airway management, the antibiotic prescription and the surgical drainage allowed the healing of the patient without medical co…

AdultMaleLudwig's Anginamedicine.medical_specialtyDiabetic ketoacidosismedicine.medical_treatmentContext (language use)Diabetes ComplicationsAnginaDiabetes mellitusmedicineHumansIntensive care medicineGeneral DentistryOdontogenic infectionbusiness.industryKetosis:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurgeryKetoacidosisOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryAirway managementLudwig's anginabusiness
researchProduct

Glycogen phosphorylase BB in acute coronary syndromes

2005

AbstractThe diagnosis of myocardial damage is preferably based on measurement of the cardiac-specific troponins. However, there is an emerging need for early, specific cardiac markers. One potential candidate is the glycogen phosphorylase BB isoenzyme (GPBB). We investigated the use of a new, commercially available GPBB ELISA assay in 61 patients presenting with an acute coronary syndrome (37 acute myocardial infarction, 24 unstable angina pectoris) in comparison to established cardiac markers such as troponin T, creatine kinase isoenzyme MB (CKMB) mass, and myoglobin. Blood samples were obtained on arrival, as well as 1, 2, 3, 4, 8, 12 and 24h later. GPBB plasma concentrations were elevate…

AdultMalemedicine.medical_specialtyAcute coronary syndromeTime FactorsClinical BiochemistryMyocardial InfarctionCoronary DiseaseEnzyme-Linked Immunosorbent AssayGlycogen phosphorylase isoenzyme BBChest painSensitivity and SpecificityAngina PectorisAnginaTroponin TInternal medicinemedicineCreatine Kinase MB FormHumansPhosphorylase bMyocardial infarctionTroponin TbiologyMyoglobinUnstable anginabusiness.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseTroponinIsoenzymesAcute DiseaseCardiologybiology.proteinmedicine.symptombusinessBiomarkersClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Copeptin Improves Early Diagnosis of Acute Myocardial Infarction

2010

ObjectivesEarly identification of myocardial infarction in chest pain patients is crucial to identify patients at risk and to maintain a fast treatment initiation.BackgroundThe aim of the current investigation is to test whether determination of copeptin, an indirect marker for arginin-vasopressin, adds diagnostic information to cardiac troponin in early evaluation of patients with suspected myocardial infarction.MethodsBetween January 2007 and July 2008, patients with suspected acute coronary syndrome were consecutively enrolled in this multicenter study. Copeptin, troponin T (TnT), myoglobin, and creatine kinase-myocardial band were determined at admission and after 3 and 6 h.ResultsOf 1,…

AdultMalemedicine.medical_specialtyAcute coronary syndromechest paindiagnosisMyocardial InfarctionChest painAngina PectorisCopeptinTroponin TPredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAgedTroponin TtroponinUnstable anginabusiness.industryMyoglobinTroponin IGlycopeptidescopeptinMiddle Agedmedicine.diseaseEarly DiagnosisCardiologyMyocardial infarction complicationsFemaleMyocardial infarction diagnosismedicine.symptombusinessCardiology and Cardiovascular MedicineBiomarkersJournal of the American College of Cardiology
researchProduct

Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysis.

2016

Soft tissue sarcoma comprises a heterogeneous group of solid malignant tumours. Comorbidities are important prognostic factors for survival and adversely impact quality of life. We examined the complex relationship between soft tissue sarcoma and comorbidities over time in a large population-based sample. The study uses routine data from the German statutory healthcare system (n = 2,615,865). Case identification of soft tissue sarcoma and comorbid diseases was based on ICD-10 codes and diagnostic modifiers. Uni- and multivariate regression models were used to obtain risk estimates for chronic somatic and mental comorbidities in soft tissue sarcoma patients compared to a cancer-free control …

AdultMalemedicine.medical_specialtyAdolescentAdjustment disordersSoft Tissue NeoplasmsComorbidityAngina03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsInternal medicineGermanymedicinePrevalenceHumans030212 general & internal medicineRisk factorChildDepression (differential diagnoses)AgedAged 80 and overbusiness.industrySoft tissue sarcomaInfantSarcomaMiddle Agedmedicine.diseaseComorbiditySurgeryOncology030220 oncology & carcinogenesisChild PreschoolRegression AnalysisFemaleSarcomabusinessAnxiety disorderEuropean journal of cancer care
researchProduct

Depression and pain: primary data and meta-analysis among 237 952 people across 47 low- and middle-income countries

2017

BackgroundDepression and pain are leading causes of global disability. However, there is a paucity of multinational population data assessing the association between depression and pain, particularly among low- and middle-income countries (LMICs) where both are common. Therefore, we investigated this association across 47 LMICs.MethodsCommunity-based data on 273 952 individuals from 47 LMICs were analysed. Multivariable logistic and linear regression analyses were performed to assess the association between the International Classification of Diseases, 10th Revision depression/depression subtypes (over the past 12 months) and pain in the previous 30 days based on self-reported data. Country…

AdultMalemedicine.medical_specialtyAdolescentComorbidityAnxietyLogistic regressionGlobal HealthSeverity of Illness IndexComorbidity; depression; depressive symptoms; pain; Applied Psychology; Psychiatry and Mental HealthAngina03 medical and health sciencesYoung Adult0302 clinical medicinedepressive symptomsInternal medicinePrevalenceMedicineHumanspainPsychiatrydepressive symptomDeveloping CountriesApplied PsychologyDepression (differential diagnoses)AgedAged 80 and overDepressive Disorderbusiness.industryPain scaleOdds ratioMiddle Agedmedicine.diseaseHealth SurveysConfidence interval030227 psychiatryPsychiatry and Mental healthMeta-analysisChronic DiseasedepressionAnxietyFemalemedicine.symptombusinessComorbidity depression depressive symptoms pain030217 neurology & neurosurgery
researchProduct

Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina

1991

PAI-1 antigen, tPA antigen and thrombin - antithrombin III complexes (TAT) levels were measured in 10 males with stable angina and type-II diabetes mellitus and in 16 males with stable angina without diabetes or other risk factors (hyperfibrinogenaemia, hyperlipidaemia, diabetes, hypertension, smoking and obesity) known to increase PAI levels. Ten healthy men of equivalent age served as controls. Because only diabetics with coronary artery disease (CAD) showed a decreased fibrinolytic capacity, a second study was performed on the 16 non-diabetic CAD patients to determine whether submaximal workload induces significant changes of tPA and PAI levels. TAT levels were increased in CAD, and sign…

AdultMalemedicine.medical_specialtyAntithrombin IIICoronary DiseaseStable anginaAngina PectorisFibrin Fibrinogen Degradation ProductsCoronary artery diseaseThrombinAntigenDiabetes mellitusInternal medicinemedicineHumanscardiovascular diseasesAgedbusiness.industryFibrinolysisPlasminogen activator inhibitor antigenAntithrombinFibrinogenHematologyGeneral MedicineMiddle Agedmedicine.diseaseObesityPlasminogen InactivatorsEndocrinologyDiabetes Mellitus Type 2Tissue Plasminogen ActivatorExercise TestbusinessPeptide Hydrolasesmedicine.drugBlood Coagulation & Fibrinolysis
researchProduct

High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease

2003

Objective— Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. PLTP-deficient mice have demonstrated increased antioxidation potential as well as a decrease in apolipoprotein B secretion and atherosclerotic lesions. In humans, high PLTP is associated with type II diabetes and obesity. Methods and Results— To assess the relationship between PLTP activity and coronary artery disease (CAD), a novel, high-throughput method to measure plasma PLTP activity was used, relating it to CAD in 1102 cases and 444 controls. This demo…

AdultMalemedicine.medical_specialtyApolipoprotein BLipoproteinsMyocardial InfarctionCoronary Artery DiseaseAngina PectorisAnginaCoronary artery diseaseReference ValuesRisk FactorsPhospholipid transfer proteinInternal medicinemedicineHumansAngina UnstablePhospholipid Transfer ProteinsRisk factorPhospholipidsAgedbiologybusiness.industryCase-control studyMembrane ProteinsBiological activityMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologyCase-Control Studiesbiology.proteinFemaleAnimal studiesCarrier ProteinsCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Short-and long-term outcome after PTCA in patients with stable and unstable angina

1990

Acute results and follow-up data over a period of 36 months after attempted PTCA in 406 patients with stable angina and 202 patients with unstable angina are reported. The rate of acute complications (death, myocardial infarction and bypass grafting (CABG) amounted to 1.5% in stable and 6.4% in unstable patients (P less than 0.005). Within the first week after PTCA a significantly lower percentage (1.7% vs 10.4%) of cardiac events (death, myocardial infarction, CABG and repeat PTCA) was observed in the stable group (P less than 0.001). During a 12-month follow-up period, another 16.3% of the patients in the stable group and 30.7% of unstable patients suffered a new cardiac event (P less tha…

AdultMalemedicine.medical_specialtyBypass graftingMyocardial InfarctionAsymptomaticAngina PectorisPostoperative ComplicationsInternal medicinemedicineHumansIn patientAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassMedical treatmentUnstable anginabusiness.industryIncidence (epidemiology)Middle AgedPrognosismedicine.diseaseQuality of LifeCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEarly phaseFollow-Up StudiesEuropean Heart Journal
researchProduct

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

2007

Aims Anderson–Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. Methods and results Clinical and laboratory data were available in 714 patients from 11 countries (mean age 35 ± 17 years, 369 women, 336 treated). The prevalence of angina was 23 vs. 22%; palpitations and arrhythmias 27 vs. 26%; exertional dyspnoea 23 vs. 23%; and syncope 2 vs. 4%, in wom…

AdultMalemedicine.medical_specialtyHeart diseaseHeart DiseasesCardiomyopathyLeft ventricular hypertrophySyncopeAnginaRisk FactorsInternal medicinemedicinePalpitationsPrevalenceHumansVascular diseasebusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryEuropeIsoenzymesDyspneaTreatment OutcomeEchocardiographyalpha-GalactosidaseFabry DiseaseFemaleHypertrophy Left Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateEuropean heart journal
researchProduct

C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery d…

2009

Abstract Objectives One third to one half of the variation in vascular disease occurrence remains unexplained by traditional risk factors. Since atherosclerosis may, in part, be an inflammatory disease, circulating factors related to inflammation may be predictors of cardiovascular disease. The aim of this study was to evaluate the association between common atherosclerotic risk factors and markers of inflammation. Design and methods Serum levels of soluble CD40 (sCD40L), high-sensitive C-reactive protein (hs-CRP) and homocysteine (Hcy) were measured in 251 patients selected from a series of 438 subjects affected by previous myocardial infarction, angina or other cardiovascular diseases. Re…

AdultMalemedicine.medical_specialtyHomocysteineClinical BiochemistryCD40 LigandEnzyme-Linked Immunosorbent AssayDiseaseCoronary Artery DiseaseCoronary artery diseaseAnginaCohort Studieschemistry.chemical_compoundRisk FactorsInternal medicinemedicineCD40Humansc-reactiveMyocardial infarctionHomocysteineFramingham Risk Scorebiologybusiness.industryVascular diseaseC-reactive proteinGeneral MedicineMiddle Agedmedicine.diseaseC-Reactive Proteinchemistrybiology.proteinCardiologyFemalebusiness
researchProduct